EQT is not a clean buy right now for a Beginner long-term investor with $50,000-$100,000 who wants to act now and not wait for a better entry. The business fundamentals are strong and analysts remain mostly positive, but the current chart is weak in the near term and the options market is leaning cautious. My direct view: hold off for now rather than buy immediately.
EQT is trading at 56.62, just above the S1 support at 56.146 and below the pivot at 58.242, which shows the stock is still under pressure. MACD histogram is negative and expanding, which signals weakening momentum. RSI_6 at 25.407 suggests the stock is near oversold, but not yet showing a confirmed reversal. Moving averages are converging, so a trend shift may be forming, but it is not confirmed. Overall, the short-term technical picture is bearish-to-neutral, not an ideal immediate entry.

["Q1 revenue rose 49.54% YoY.", "Q1 net income rose 514.20% YoY.", "Q1 EPS increased 490.00% YoY.", "Gross margin expanded to 67.64%, up 22.89% YoY.", "Citi, Jefferies, Wells Fargo, BMO, Morgan Stanley, and Truist all maintain bullish or positive views with price targets mostly in the $70-$79 range.", "Recent Americold joint venture announcement adds a strategic headline catalyst."]
["Price action is weak, with the stock trading below the pivot and showing negative MACD momentum.", "Roth Capital kept a Neutral rating and highlighted a large Q1 derivatives loss from hedging.", "TPH&Co. downgraded the stock to Hold earlier in the period.", "Hedge funds and insiders are both neutral with no significant buying trend.", "The options market shows elevated put open interest, which signals caution."]
In Q1 2026, EQT delivered very strong growth. Revenue reached 3.62B, up 49.54% YoY. Net income jumped to 1.49B, up 514.20% YoY, and EPS rose to 2.36, up 490.00% YoY. Gross margin improved to 67.64%, up 22.89% YoY. This is an excellent quarterly result and confirms improving operating performance in the latest quarter.
Analyst sentiment is broadly positive and has trended upward overall. Citi raised its target to $70 and kept Buy, Jefferies raised to $77 and kept Buy, UBS slightly lowered to $74 but kept Buy, Wells Fargo raised to $79 and kept Overweight, Stephens trimmed to $73 but kept Overweight, Roth stayed Neutral at $57, TPH&Co. downgraded to Hold, BMO raised to $76 and kept Outperform, Morgan Stanley raised to $74 and kept Overweight, and Truist initiated Buy at $74. Wall Street pros are mostly bullish on EQT’s gas demand, free cash flow, and LNG/power-demand tailwinds, while the main con is that some analysts are still concerned about hedging losses and near-term macro sensitivity.